Point Mutation of Tyrosine 759 of the IL-6 Family Cytokine Receptor, Gp130, Augments Collagen-induced Arthritis in DBA/1J Mice
Overview
Physiology
Affiliations
Background: Knock-in mice (gp130F759) with a Y759F point mutation in gp130, a signal transducing receptor subunit shared by members of the IL-6 cytokine family, show sustained activation of STAT3, enhanced acute-phase or immune responses, and autoimmune arthritis. We conducted a detailed analysis of collagen-induced arthritis (CIA) in gp130F759 with a DBA/1J background (D/J.gp130F759).
Methods: We backcrossed gp130F759 to C57BL/6 and DBA/1J, and compared the pathologic changes, including occurrence of arthritis, in the two distinct genetic backgrounds. We analyzed CIA in D/J.gp130F759 and investigated the effects of methotrexate (MTX) on CIA.
Results: C57BL/6 background gp130F759 mice, but not D/J.gp130F759, spontaneously developed polyarthritis and glomerulonephritis. On the other hand, keratitis of the eyes only developed in D/J.gp130F759, indicating the influence of genetic background on disease development in gp130F759 mice. Resistance of the DBA/1J background against spontaneous arthritis urged us to examine CIA in D/J.gp130F759. CIA in D/J.gp130F759 was more severe, with greater bone destruction, than the control mice. After collagen immunization, splenomegaly and serum levels of rheumatoid factor and anti-DNA antibody were augmented in D/J.gp130F759. Bio-Plex analysis of serum cytokines revealed increased IL-12p40 and PDGF-BB before immunization, and increased levels of IFN-gamma, IL-17, TNF-alpha, IL-9, and MIP-1beta 8 days after the booster dose. IL-6 and PDGF-BB in D/J.gp130F759 showed distinct kinetics from the other cytokines; higher levels were observed after arthritis development. MTX partially attenuated the development of arthritis and inhibited bone destruction in D/J.gp130F759, with reduction of anti-type II collagen antibody levels, suggesting that MTX mainly affects antigen-specific immune responses in CIA.
Conclusion: The Tyr-759 point mutation of the IL-6 family cytokine receptor subunit, gp130, caused autoimmune disease, and this was also influenced by the genetic background. CIA in D/J.gp130F759 is useful for evaluating drugs in a relatively short period because sustained activation of STAT3 may enhance the disease symptoms.
Hashida R, Shimozuru Y, Chang J, Agosto-Marlin I, Waritani T, Terato K Autoimmune Dis. 2021; 2021:7385106.
PMID: 33833871 PMC: 8016593. DOI: 10.1155/2021/7385106.
Khanfar E, Olasz K, Gabris F, Gajdocsi E, Botz B, Kiss T Int J Mol Sci. 2020; 21(17).
PMID: 32859051 PMC: 7503974. DOI: 10.3390/ijms21176162.
Pien Tze Huang alleviate the joint inflammation in collagen-induced arthritis mice.
Deng Y, Luo H, Shu J, Shu H, Lu C, Zhao N Chin Med. 2020; 15:30.
PMID: 32256686 PMC: 7106633. DOI: 10.1186/s13020-020-00311-3.
Koyama A, Tanaka A, To H J Pharm Pharmacol. 2017; 69(9):1145-1154.
PMID: 28560778 PMC: 5575561. DOI: 10.1111/jphp.12752.
Recent advances in neutralizing the IL-6 pathway in arthritis.
Malemud C Open Access Rheumatol. 2009; 1:133-150.
PMID: 27789987 PMC: 5074717. DOI: 10.2147/oarrr.s6266.